The DOI matches its Crossref record; 19 of the 19 references it cites were found in a registry or an index.
Early postnatal dexamethasone treatment and increased incidence of cerebral palsy
Open accessAbstract
OBJECTIVE: To study the long term neurodevelopmental outcome of children who participated in a randomised, double blind, placebo controlled study of early postnatal dexamethasone treatment for prevention of chronic lung disease. METHODS: The original study compared a three day course of dexamethasone (n = 132) with a saline placebo (n = 116) administered from before 12 hours of age in preterm infants, who were ventilated for respiratory distress syndrome and had received surfactant treatment. Dexamethasone treatment was associated with an increased incidence of hypertension, hyperglycaemia, and gastrointestinal haemorrhage and no reduction in either the incidence or severity of chronic lung disease or mortality. A total of 195 infants survived to discharge and five died later. Follow up data were obtained on 159 of 190 survivors at a mean (SD) age of 53 (18) months. RESULTS: No differences were found between the groups in terms of perinatal or neonatal course, antenatal steroid administration, severity of initial disease, or major neonatal morbidity. Dexamethasone treated children had a significantly higher incidence of cerebral palsy than those receiving placebo (39/80 (49%) v 12/79 (15%) respectively; odds ratio (OR) 4.62, 95% confidence interval (95% CI) 2.38 to 8.98). The most common form of cerebral palsy was spastic diplegia (incidence 22/80 (28%) v 5/79 (6%) in dexamethasone and placebo treated infants respectively; OR 4.45, 95% CI 1.95 to 10.15). Developmental delay was significantly more common in the dexamethasone treated group (44/80 (55%)) than in the placebo treated group (23/79 (29%); OR 2.87, 95% CI 1.53 to 5.38). Dexamethasone treated infants had more periventricular leucomalacia and less intraventricular haemorrhage in the neonatal period than those in the placebo group, although these differences were not statistically significant. Eleven children with cerebral palsy had normal ultrasound scans in the neonatal period; all 11 had received dexamethasone. Logistic regression analysis showed both periventricular leucomalacia and drug assignment to dexamethasone to be highly significant predictors of abnormal neurological outcome. CONCLUSIONS: A three day course of dexamethasone administered shortly after birth in preterm infants with respiratory distress syndrome is associated with a significantly increased incidence of cerebral palsy and developmental delay.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Evidence-Based Medicine: How to Practice and Teach EBM
Sackett, D. L. (2000) · Cited by 5,950
Evidence Based Medicine—How to Practice and Teach EBM
Jones, K. (1996) · BMJ · doi:10.1136/bmj.313.7069.1410 · Cited by 525
A Controlled Trial of Dexamethasone in Preterm Infants at High Risk for Bronchopulmonary Dysplasia
Cummings, J. J., D'Eugenio, D. B., & Gross, S. J. (1989) · New England Journal of Medicine · doi:10.1056/nejm198906083202301 · Cited by 483
Antenatal Glucocorticoid Treatment and Cystic Periventricular Leukomalacia in Very Premature Infants
Baud, O., Foix-L'Helias, L., Kaminski, M., Audibert, F., Jarreau, P.-H., Papiernik, E., Huon, C., Lepercq, J., Dehan, M., & Lacaze-Masmonteil, T. (1999) · New England Journal of Medicine · doi:10.1056/nejm199910143411604 · Cited by 414
O'Shea, T. M., Kothadia, J. M., Klinepeter, K. L., Goldstein, D. J., Jackson, B. G., Weaver, R. G., & Dillard, I. A. R. G. (1999) · Pediatrics · doi:10.1542/peds.104.1.15 · Cited by 376
Yeh, T. F., Lin, Y. J., Hsieh, W. S., Lin, H. C., Lin, C. H., Chen, J. Y., Kao, H. A., & Chien, C. H. (1997) · Pediatrics · doi:10.1542/peds.100.4.e3 · Cited by 184
A CONTROLLED TRIAL OF HYDROCORTISONE THERAPY IN INFANTS WITH RESPIRATORY DISTRESS SYNDROME
Baden, M., Bauer, C. R., Colle, E., Klein, G., Taeusch, H. W., & Stern, L. (1972) · Pediatrics · doi:10.1542/peds.50.4.526 · Cited by 179
A Multicenter Trial of Two Dexamethasone Regimens in Ventilator-Dependent Premature Infants
Papile, L.-A., Tyson, J. E., Stoll, B. J., Wright, L. L., Donovan, E. F., Bauer, C. R., Krause-Steinrauf, H., Verter, J., Korones, S. B., Lemons, J. A., et al. (1998) · New England Journal of Medicine · doi:10.1056/nejm199804163381604 · Cited by 172
Perinatal treatment with glucocorticoids and the risk of maldevelopment of the brain
BENEOVA, O. (1989) · Neuropharmacology · doi:10.1016/0028-3908(89)90073-7 · Cited by 117
Clinical Trials of Postnatal Corticosteroids: Inhaled and Systemic
Halliday, H. L. (1999) · Neonatology · doi:10.1159/000047044 · Cited by 104
Cited by
Neurobiology of Periventricular Leukomalacia in the Premature Infant
Volpe, J. J. (2001) · Pediatric Research · doi:10.1203/00006450-200111000-00003 · Cited by 948
Outcomes at School Age after Postnatal Dexamethasone Therapy for Lung Disease of Prematurity
Yeh, T. F., Lin, Y. J., Lin, H. C., Huang, C. C., Hsieh, W. S., Lin, C. H., & Tsai, C. H. (2004) · New England Journal of Medicine · doi:10.1056/nejmoa032089 · Cited by 596
Postnatal Corticosteroids to Treat or Prevent Chronic Lung Disease in Preterm Infants
Committee on Fetus and Newborn (2002) · Pediatrics · doi:10.1542/peds.109.2.330 · Cited by 442
Barrington, K. J. (2001) · BMC Pediatrics · doi:10.1186/1471-2431-1-1 · Cited by 421
Long-term outcomes after repeat doses of antenatal corticosteroids
Wapner, R. J., Sorokin, Y., Mele, L., Johnson, F., Dudley, D. J., Spong, C. Y., Peaceman, A. M., Leveno, K. J., Malone, F., Caritis, S. N., et al. (2007) · New England Journal of Medicine · doi:10.1056/nejmoa071453 · Cited by 336
The role of prenatal stress in the etiology of developmental behavioural disorders
Kofman, O. (2002) · Neuroscience & Biobehavioral Reviews · doi:10.1016/s0149-7634(02)00015-5 · Cited by 332
Glucocorticoids and lung development in the fetus and preterm infant
Bolt, R. J., van Weissenbruch, M. M., Lafeber, H. N., & Delemarre‐van de Waal, H. A. (2001) · Pediatric Pulmonology · doi:10.1002/ppul.1092 · Cited by 305
Early postnatal (<96 hours) corticosteroids for preventing chronic lung disease in preterm infants
Halliday, H., Ehrenkranz, R., & Doyle, L. (2003) · The Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd001146 · Cited by 303
Early (< 8 days) postnatal corticosteroids for preventing chronic lung disease in preterm infants
Halliday, H. L., Ehrenkranz, R. A., & Doyle, L. W. (2009) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd001146.pub2 · Cited by 298
Birth Prevalence of Cerebral Palsy: A Population-Based Study
Van Naarden Braun, K., Doernberg, N., Schieve, L., Christensen, D., Goodman, A., & Yeargin-Allsopp, M. (2016) · Pediatrics · doi:10.1542/peds.2015-2872 · Cited by 265
Doyle, L. W., Cheong, J. L., Ehrenkranz, R. A., & Halliday, H. L. (2017) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd001146.pub5 · Cited by 260
Neurodevelopmental Outcome of Bronchopulmonary Dysplasia
Anderson, P. J., & Doyle, L. W. (2006) · Seminars in Perinatology · doi:10.1053/j.semperi.2006.05.010 · Cited by 252
Algra, S. O., Jansen, N. J. G., van der Tweel, I., Schouten, A. N. J., Groenendaal, F., Toet, M., van Oeveren, W., van Haastert, I. C., Schoof, P. H., de Vries, L. S., et al. (2014) · Circulation · doi:10.1161/circulationaha.113.003312 · Cited by 163
Feng, Y., Rhodes, P. G., Liu, H., & Bhatt, A. J. (2009) · Neuroscience · doi:10.1016/j.neuroscience.2008.10.024 · Cited by 29
Metadata
- Authors
- Shinwell, E. S., Karplus, M., Reich, D., Weintraub, Z., Blazer, S., Bader, D., Yurman, S., Dolfin, T., Kogan, A., Dollberg, S., Arbel, E., Goldberg, M., Gur, I., Naor, N., Sirota, L., Mogilner, S., Zaritsky, A., Barak, M., & Gottfried, E.
- Venue
- Archives of Disease in Childhood - Fetal and Neonatal Edition
- Publisher
- BMJ
- Published
- 2000-11-01
- Volume
- 83
- Issue
- 3
- Pages
- F177-F181
- ISSN
- 1359-2998 (ISSN-L)
- 1468-2052
- OpenAlex
- W2141078013
- Cited by
- 368
- References
- 19
- FWCI
- 21.75
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.